{
  "pmcid": "11887560",
  "sha256": "0b8c4e6ab6bbf06a79623d63322afa842481689a91f0f802510d11dbf3664d77",
  "timestamp_utc": "2025-11-09T15:25:30.450990+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.879120077783181,
    "reading_ease": 28.080391346621326,
    "word_count": 242
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary end points were technical success and 12-month primary patency."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Technical success was superior for CSG, BMS, and A+DCB compared with PTA, while A+DCB and CSG were superior to DCB."
      },
      "Harms": {
        "score": 1,
        "evidence": "There were no significant differences in 12-month mortality or major amputation."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 4,
    "max_score": 25
  }
}